PF-06456384 trihydrochloride

Modify Date: 2024-01-12 12:55:13

PF-06456384 trihydrochloride Structure
PF-06456384 trihydrochloride structure
Common Name PF-06456384 trihydrochloride
CAS Number 1834610-75-1 Molecular Weight 719.799
Density 1.5±0.1 g/cm3 Boiling Point 789.8±70.0 °C at 760 mmHg
Molecular Formula C35H32F3N7O3S2 Melting Point N/A
MSDS N/A Flash Point 431.4±35.7 °C

 Use of PF-06456384 trihydrochloride


PF-06447475 trihydrochloride is a highly potent, selective, brain penetrant LRRK2 kinase inhibitor with IC50 values of 3 nM and 11 nM for WT LRRK and G2019S LRRK2, respectively. PF-06447475 trihydrochloride can be used for parkinson's disease (PD) research[1].

 Names

Name 3-Cyano-4-({3-[2-({[2-(4-piperidinyl)ethyl]amino}methyl)-4-pyridinyl]-3'-(trifluoromethyl)-4-biphenylyl}oxy)-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide
Synonym More Synonyms

 PF-06456384 trihydrochloride Biological Activity

Description PF-06447475 trihydrochloride is a highly potent, selective, brain penetrant LRRK2 kinase inhibitor with IC50 values of 3 nM and 11 nM for WT LRRK and G2019S LRRK2, respectively. PF-06447475 trihydrochloride can be used for parkinson's disease (PD) research[1].
Related Catalog
References

[1]. Jaclyn L Henderson, et al. Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor. J Med Chem. 2015 Jan 8;58(1):419-32.

 Chemical & Physical Properties

Density 1.5±0.1 g/cm3
Boiling Point 789.8±70.0 °C at 760 mmHg
Molecular Formula C35H32F3N7O3S2
Molecular Weight 719.799
Flash Point 431.4±35.7 °C
Exact Mass 719.195984
LogP 6.95
Vapour Pressure 0.0±2.8 mmHg at 25°C
Index of Refraction 1.666

 Synonyms

3-Cyano-4-[[3-[2-[[[2-(4-piperidinyl)ethyl]amino]methyl]-4-pyridinyl]-3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]oxy]-N-1,2,4-thiadiazol-5-yl-benzenesulfonamide trihydrochloride
Benzenesulfonamide, 3-cyano-4-[[3-[2-[[[2-(4-piperidinyl)ethyl]amino]methyl]-4-pyridinyl]-3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]oxy]-N-1,2,4-thiadiazol-5-yl-, hydrochloride (1:3)
Benzenesulfonamide, 3-cyano-4-[[3-[2-[[[2-(4-piperidinyl)ethyl]amino]methyl]-4-pyridinyl]-3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]oxy]-N-1,2,4-thiadiazol-5-yl-
3-Cyano-4-({3-[2-({[2-(4-piperidinyl)ethyl]amino}methyl)-4-pyridinyl]-3'-(trifluoromethyl)-4-biphenylyl}oxy)-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide